Selected article for: "population proportion and severe disease"
Author: Hulikal, Narendra; Kumar, Singaram Nagesh; Gopinath, Kodaganuru S.
Title: Surgery for Cancer in the Wake of Second and Future Waves! Challenges and Opportunities in the Indian Context
  • Cord-id: 1bfr9she
  • Document date: 2021_7_30
    • ID: 1bfr9she
    Snippet: The pandemic situation created by newly discovered severe acute respiratory disease corona virus 2019 has thrown up many challenges to surgical fraternity across world. All surgeons particularly cancer surgeons are facing dilemmas not only in managing patients but also in appropriate personal as well as employee’s health protection as well. Since the pandemic is not expected to recede unless it affects a considerable proportion of population or up to 60% of population is vaccinated, we need to
    Document: The pandemic situation created by newly discovered severe acute respiratory disease corona virus 2019 has thrown up many challenges to surgical fraternity across world. All surgeons particularly cancer surgeons are facing dilemmas not only in managing patients but also in appropriate personal as well as employee’s health protection as well. Since the pandemic is not expected to recede unless it affects a considerable proportion of population or up to 60% of population is vaccinated, we need to be aware of prevailing best practices. This is important in ensuring continuity of care for cancer patients as well as to limit the consequences of one getting infected with the COVID-19. This review article focuses on the current challenges and the ways to mitigate them.

    Search related documents:
    Co phrase search for related documents
    • active cancer and acute respiratory syndrome virus: 1
    • active cancer and locally advanced: 1, 2
    • active cancer and low mortality: 1
    • active cancer and lung hematologic: 1
    • active cancer and lung kidney: 1, 2
    • active cancer and lung kidney bladder liver: 1
    • active cancer patient and acute respiratory syndrome: 1
    • active cancer treatment and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • active cancer treatment and acute respiratory syndrome virus: 1
    • active cancer treatment and locally advanced: 1
    • active cancer treatment and low mortality: 1
    • active cancer treatment and lung hematologic: 1
    • active infection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • active infection and acute respiratory syndrome virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • active infection and low mortality: 1
    • active infection and low sensitivity: 1, 2, 3
    • active infection and lung kidney: 1
    • actual management and acute respiratory syndrome: 1, 2, 3
    • actual management and low mortality: 1